Update: Interim Guidance for Health Care Providers for Managing Patients with Suspected E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, November 2019
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
CDC, the Food and Drug Administration (FDA), state and local health departments, and public health and clinical stakeholders are investigating a nationwide outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI) (1). CDC has published recommendations for health care providers regarding EVALI (2-4). Recently, researchers from Utah and New York published proposed diagnosis and treatment algorithms for EVALI (5,6). EVALI remains a diagnosis of exclusion because, at present, no specific test or marker exists for its diagnosis, and evaluation should be guided by clinical judgment. Because patients with EVALI can experience symptoms similar to those associated with influenza or other respiratory infections (e.g., fever, cough, headache, myalgias, or fatigue), it might be difficult to differentiate EVALI from influenza or community-acquired pneumonia on initial assessment; EVALI might also co-occur with respiratory infections. This report summarizes recommendations for health care providers managing patients with suspected or known EVALI when respiratory infections such as influenza are more prevalent in the community than they have been in recent months (7). Recommendations include 1) asking patients with respiratory, gastrointestinal, or constitutional symptoms about the use of e-cigarette, or vaping, products; 2) evaluating those suspected to have EVALI with pulse oximetry and obtaining chest imaging, as clinically indicated; 3) considering outpatient management for clinically stable EVALI patients who meet certain criteria; 4) testing patients for influenza, particularly during influenza season, and administering antimicrobials, including antivirals, in accordance with established guidelines; 5) using caution when considering prescribing corticosteroids for outpatients, because this treatment modality has not been well studied among outpatients, and corticosteroids could worsen respiratory infections; 6) recommending evidence-based treatment strategies, including behavioral counseling, to help patients discontinue using e-cigarette, or vaping, products; and 7) emphasizing the importance of annual influenza vaccination for all persons aged ≥6 months, including patients who use e-cigarette, or vaping products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201908-1581st · Cited by 3,657 · cited 3×
“Corticosteroids might worsen respiratory infections commonly seen in the outpatient setting (13,14).”
BackgroundMethodPulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin—Final Report
Layden, J. E., Ghinai, I., Pray, I., Kimball, A., Layer, M., Tenforde, M. W., Navon, L., Hoots, B., Salvatore, P. P., Elderbrook, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911614 · Cited by 911 · cited 2×
“The physical exam should include assessment of vital signs and pulse oximetry; tachycardia, tachypnea, and hypoxemia have been commonly reported among cases (4,9,10).”
BackgroundSelf-citationBudney, A. J., Moore, B. A., Rocha, H. L., & Higgins, S. T. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.4.2.307 · Cited by 290
Siegel, D. A., Jatlaoui, T. C., Koumans, E. H., Kiernan, E. A., Layer, M., Cates, J. E., Kimball, A., Weissman, D. N., Petersen, E. E., Reagan-Steiner, S., et al. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6841e3 · Cited by 265
Self-citationSevere pulmonary disease associated with electronic-cigarette–product use—interim Guidance
Schier, J. G., Meiman, J. G., Layden, J., Mikosz, C. A., VanFrank, B., King, B. A., Salvatore, P. P., Weissman, D. N., Thomas, J., Melstrom, P. C., et al. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6836e2 · Cited by 246
Self-citationChatham-Stephens, K., Roguski, K., Jang, Y., Cho, P., Jatlaoui, T. C., Kabbani, S., Glidden, E., Ussery, E. N., Trivers, K. F., Evans, M. E., et al. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6846e1 · Cited by 93
Self-citation
Cited by
Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin—Final Report
Layden, J. E., Ghinai, I., Pray, I., Kimball, A., Layer, M., Tenforde, M. W., Navon, L., Hoots, B., Salvatore, P. P., Elderbrook, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911614 · Cited by 911
Self-citationChatham-Stephens, K., Roguski, K., Jang, Y., Cho, P., Jatlaoui, T. C., Kabbani, S., Glidden, E., Ussery, E. N., Trivers, K. F., Evans, M. E., et al. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6846e1 · Cited by 93
Self-citationLessons from the public health responses to the US outbreak of vaping‐related lung injury
Hall, W., Gartner, C., & Bonevski, B. (2021) · Addiction · doi:10.1111/add.15108 · Cited by 66
Metadata
- Authors
- Jatlaoui, T. C., Wiltz, J. L., Kabbani, S., Siegel, D. A., Koppaka, R., Montandon, M., Adkins, S. H., Weissman, D. N., Koumans, E. H., O’Hegarty, M., O’Sullivan, M. C., Ritchey, M. D., Chatham-Stephens, K., Kiernan, E. A., Layer, M., Reagan-Steiner, S., Legha, J. K., Shealy, K., King, B. A., Jones, C. M., Baldwin, G. T., Rose, D. A., Delaney, L. J., Briss, P., Evans, M. E., Lung Injury Response Clinical Working Group, Lung Injury Response Clinical Working Group, Aberegg, S., Calfee, C. S., Callahan, S. J., Esper, A., Griffiths, A., Harris, D., Hayes, D., Rao, D. R., & Smith, L. S.
- Venue
- MMWR. Morbidity and Mortality Weekly Report
- Published
- 2019-11-22
- Volume
- 68
- Issue
- 46
- Pages
- 1081-1086
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- OpenAlex
- W2991052249
- Cited by
- 96
- References
- 6
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Update: Interim Guidance for Health Care Providers for Managing Patients with Suspected E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, November 2019. https://app.cochat.ai/papers/10.15585/mmwr.mm6846e2
- The paper
- Jatlaoui, T. C., Wiltz, J. L., Kabbani, S., Siegel, D. A., Koppaka, R., Montandon, M., Adkins, S. H., Weissman, D. N., Koumans, E. H., O’Hegarty, M., O’Sullivan, M. C., Ritchey, M. D., Chatham-Stephens, K., Kiernan, E. A., Layer, M., Reagan-Steiner, S., Legha, J. K., Shealy, K., King, B. A., . . . Smith, L. S. (2019). Update: Interim Guidance for Health Care Providers for Managing Patients with Suspected E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, November 2019. MMWR. Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm6846e2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.